» Articles » PMID: 33492641

Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria

Overview
Journal Infect Dis Ther
Date 2021 Jan 25
PMID 33492641
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

The global emergence of carbapenemase-producing bacteria capable of hydrolyzing the once effective carbapenem antibiotics is considered a contemporary public health concern. Carbapenemase enzymes, once constrained to isolates of Klebsiella pneumoniae, are now routinely reported in different bacteria within the Enterobacterales order of bacteria, creating the acronym CRE which now defines Carbapenem-Resistant Enterobacterales. CRE harboring different types of enzymes, including the most prevalent types KPC, VIM, IMP, NDM, and OXA-48, are now routinely reported and more importantly, are now frequently present in many infections world-wide. Defining and updating the contemporary epidemiology of both the US and global burden of carbapenem-resistant infections is now more important than ever. This review describes the global distribution and continued evolution of carbapenemases which continue to spread at alarming rates. Informed understanding of the current epidemiology of CRE, coupled with advances in antibiotic options, and the use rapid diagnostics offers the potential for rapid identification and management of carbapenem-resistant infections.

Citing Articles

In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producers.

Boattini M, Gaibani P, Comini S, Costa C, Cavallo R, Broccolo F Eur J Clin Microbiol Infect Dis. 2025; .

PMID: 40064744 DOI: 10.1007/s10096-025-05080-1.


Rapid Simultaneous Detection of the Clinically Relevant Carbapenemase Resistance Genes KPC, OXA48, VIM and NDM with the Newly Developed Ready-to-Use qPCR CarbaScan LyoBead.

Reinicke M, Diezel C, Teimoori S, Haase B, Monecke S, Ehricht R Int J Mol Sci. 2025; 26(3).

PMID: 39940986 PMC: 11818240. DOI: 10.3390/ijms26031218.


Performance of Ertapenem-Supplemented MacConkey Agar (MacErt) for Detecting Carbapenemase-Producing Enterobacterales.

Sow O, Cisse A, Ndiaye I, Niang E, Kane F, Cisse K Cureus. 2024; 16(11):e74106.

PMID: 39712805 PMC: 11661862. DOI: 10.7759/cureus.74106.


Laboratory detection of carbapenemases among Gram-negative organisms.

Simner P, Pitout J, Dingle T Clin Microbiol Rev. 2024; 37(4):e0005422.

PMID: 39545731 PMC: 11629623. DOI: 10.1128/cmr.00054-22.


Prevalence of carbapenem-resistant (CRE) in Saudi Arabia: A systematic review and meta-analysis.

Alshehri A, Irekeola A Saudi Pharm J. 2024; 32(11):102186.

PMID: 39498344 PMC: 11532984. DOI: 10.1016/j.jsps.2024.102186.


References
1.
ABRAHAM E, CHAIN E . An enzyme from bacteria able to destroy penicillin. 1940. Rev Infect Dis. 1988; 10(4):677-8. View

2.
Kazmierczak K, Tsuji M, Wise M, Hackel M, Yamano Y, Echols R . In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates.... Int J Antimicrob Agents. 2018; 53(2):177-184. DOI: 10.1016/j.ijantimicag.2018.10.007. View

3.
Walters M, Witwer M, Lee Y, Albrecht V, Lonsway D, Rasheed J . Notes from the Field: Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Less Common Enterobacteriaceae Genera - United States, 2014-2017. MMWR Morb Mortal Wkly Rep. 2018; 67(23):668-669. PMC: 6002034. DOI: 10.15585/mmwr.mm6723a4. View

4.
Jacoby G . AmpC beta-lactamases. Clin Microbiol Rev. 2009; 22(1):161-82, Table of Contents. PMC: 2620637. DOI: 10.1128/CMR.00036-08. View

5.
Nelson K, Hemarajata P, Sun D, Rubio-Aparicio D, Tsivkovski R, Yang S . Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity. Antimicrob Agents Chemother. 2017; 61(10). PMC: 5610495. DOI: 10.1128/AAC.00989-17. View